Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
IPO Year: 2001
Exchange: NASDAQ
Website: aligntech.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/10/2025 | $140.00 | Buy → Hold | Jefferies |
| 7/31/2025 | $154.00 | Overweight → Equal-Weight | Morgan Stanley |
| 4/25/2025 | $170.00 | Buy → Hold | HSBC Securities |
| 2/14/2025 | $255.00 | Overweight | Wells Fargo |
| 1/6/2025 | $235.00 → $280.00 | Market Perform → Outperform | Leerink Partners |
| 12/4/2024 | $295.00 | Outperform | Mizuho |
| 10/10/2024 | Hold | Needham | |
| 2/26/2024 | $310.00 | Market Perform | Leerink Partners |
| 12/11/2023 | $197.00 | Neutral → Sell | Goldman |
| 10/27/2023 | $200.00 | Buy → Neutral | UBS |
Fastest customizable press release news feed in the world
Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month. Conference: UBS Global Healthcare Conference Date: Tuesday, November 11, 2025
2026 Grant Application Process Now Open for Up to $300,000 in Funding Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the opening of its 2026 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology's
Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our guidance Q3'25 Clear Aligner volume increased 4.9% year-over-year reflecting strength internationally, and increased 0.5% sequentially reflecting strength from teens and kids Q3'25 Clear Aligner volume for teens and kids increased 8.3% year-over-year and 14.7% sequentially, driven by increased doctor submitters and continued adoption of Invisalign First™ Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our Q3'25 outlook range of $965 million to $985 million Q3'25 total revenues were favorably impa
ClinCheck Live Plan represents a major technological milestone in the Align™ Digital Platform, that can reduce the Invisalign treatment planning cycle from days to minutes and lead to patients starting treatment faster. Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced ClinCheck® Live Plan, a new feature in its Invisalign® digital treatment planning that automates the generation of initial doctor-ready treatment plans within 15 minutes. This advancement represents a major technological milestone in the Align™ D
Series of new features enable patients to see their comprehensive oral health condition and potential future Invisalign® smile through dynamic visuals at chairside on an iTero scanner, which also fabricates mock-ups and prosthetics in-house, transforming dental consultations that set a new standard of care to deliver elevated care, build trust, and increase treatment acceptance. Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today announced a series of new product innovations for iTero™ Digital Solutions, a comprehensive
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b
Over 100 Invisalign® and iTero™-trained doctor educators from around the world spent 2 1/2 days immersed in deep-dive education workshops focused on Align's latest innovations and clinical evidence for kids, teens and adults, global best practices using Invisalign and iTero™ solutions, and Align's next generation technologies. Announced Align's new clinical evidence webpage with access to 800+ peer-reviewed clinical publications and expanded the Align Global Gallery™, which features more than 1,500 Invisalign® case studies, and the Align research awards program which represents over $4 million in grants since it was launched in 2010 to support clinical and scientific orthodontic and den
Asserts patents around innovations in clear aligner therapy; seeks exclusion and cease-and-desist orders Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has filed a complaint under Section 337 of the Tariff Act (which prohibits unfair competition and acts in the importation and/or sale of goods) with the U.S. International Trade Commission ("ITC") against Angelalign Technology, Inc. ("Angel") for the unauthorized importation and sale of clea
Clinical Workshops and Innovation Hub Showcased Solutions to Enhance Digital Orthodontics, Comprehensive Dentistry, and Ortho-Restorative Workflows Celebrations honored doctors and practice teams who have helped transform 20M+ Smiles with Invisalign Treatment Align Women's Smile Collective initiative launched to celebrate, support, and spotlight women shaping the future of dentistry Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights fro
Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. As noted below, the presentations will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month. Conference: 2025 Wells Fargo Healthcare Conference Date: Wednesday, September 3
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
3 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
S-8 - ALIGN TECHNOLOGY INC (0001097149) (Filer)
10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
SD - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Jefferies downgraded Align Tech from Buy to Hold and set a new price target of $140.00
Morgan Stanley downgraded Align Tech from Overweight to Equal-Weight and set a new price target of $154.00
HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00
Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00
Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously
Mizuho initiated coverage of Align Tech with a rating of Outperform and set a new price target of $295.00
Needham initiated coverage of Align Tech with a rating of Hold
Leerink Partners initiated coverage of Align Tech with a rating of Market Perform and set a new price target of $310.00
Goldman downgraded Align Tech from Neutral to Sell and set a new price target of $197.00
UBS downgraded Align Tech from Buy to Neutral and set a new price target of $200.00
Live Leadership Updates
Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition
TEMPE, Ariz., SAN JOSE, Calif., and SINGAPORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Raj Pudipeddi, Align Technology chief product and marketing officer, and senior vice president will assume additional responsibility for the commercial organization in the Asia Pacific region as managing director, effective immediately, succeeding Julie Tay, Align Technology senior vice president and managing director, Asia Pacifi
Live finance-specific insights
Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our guidance Q3'25 Clear Aligner volume increased 4.9% year-over-year reflecting strength internationally, and increased 0.5% sequentially reflecting strength from teens and kids Q3'25 Clear Aligner volume for teens and kids increased 8.3% year-over-year and 14.7% sequentially, driven by increased doctor submitters and continued adoption of Invisalign First™ Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our Q3'25 outlook range of $965 million to $985 million Q3'25 total revenues were favorably impa
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b
Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year Q2'25 Clear Aligner volume was 644.4 thousand cases, up 0.3% sequentially and year-over-year Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially and up 5.6% year-over-year Q2'25 operating income of $163.0 million and operating margin of 16.1%, non
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi
Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2024 financial results on Wednesday, February 5, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call w
Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million, increased 1.8% year-over-year, and Q3'24 diluted net income per share was $1.55, or $2.35 on a non-GAAP diluted basis Q3'24 total revenues were unfavorably impacted by foreign exchange by approximately $14.6 million year-over-year(1), and were not significantly impacted sequentially Q3'24 operating income of $162.3 million and operating margin of 16.6%, non-GAAP operating margin of 22.1% Q3'24 GAAP operating margin was unfavorably impacted by foreign exchange by approximately 0.8 points year-over-year(1), and was not significantly impacted sequentially
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2024 financial results on Wednesday, October 23, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
This live feed shows all institutional transactions in real time.
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)